Scientists have developed a new AI model to identify which cancer patients would respond best to a targeted drug on the NHS.
PhenMap tool could spare thousands of patients from treatment that would be ineffective for them ...
The approval also covers Keytruda SC, known in the US as Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results